Send Inquiry

Request To Call Back

Bortezomib 3 5mg Injection

Name: Bortezomib 3 5mg Injection
Brand: QUICKWELL PHARMA LLP
Price: 2500 INR
Availability: InStock

Price 2500 INR/ Vial

Get a Price/Quote

MOQ : 50 Vials

Bortezomib 3 5mg Injection Specification

Dosage Form
Injection

Indication
Multiple Myeloma, Mantle Cell Lymphoma

Salt Composition
Bortezomib

Pacakaging (Quantity Per Box)
1 Vial per box

Life Span
24 months (shelf life)

Brand Name
Bortenat

Packaging Type
Vial

Origin of Medicine
India

Drug Type
Prescription

Ingredients
Bortezomib

Physical Form
Lyophilized Powder

Function
Antineoplastic (Anti-cancer)

Recommended For
Multiple Myeloma, Mantle Cell Lymphoma

Dosage
3.5 mg per vial

Dosage Guidelines
As directed by physician

Suitable For
Adults

Quantity
1 Vial

Storage Instructions
Store below 25C, protect from light

Cytotoxic Warning
Yes

Administration Mode
Intravenous/Subcutaneous

Prescription Required
Yes only

Diluent Compatibility
Normal saline

Storage Temp
Room temperature

Sterile Preparation
Yes

Form
Lyophilized

Marketed By
Natco Pharma Ltd.

Route
IV or SC

Reconstitution Required
Yes

Strength
3.5 mg

Usage
Hematologic malignancy

Pack Size
Vial

Bortezomib 3 5mg Injection Trade Information

Minimum Order Quantity
50 Vials

Payment Terms
Cash in Advance (CID)

Supply Ability
500 Vials Per Month

Delivery Time
7 Days

Main Domestic Market
All India

Bortezomib 3 5mg Injection About

Experience the grand efficacy of Bortezomib 3.5mg Injection from Natco Pharma Ltd., a sterling solution for adults battling multiple myeloma and mantle cell lymphoma. This lyophilized opulent powder offers outstanding anti-neoplastic potency, delivered via IV or SC routes with notable safety and cytotoxic precautions. Its affordable price garners sizzling demand and favorable reviews from healthcare professionals. Each sterile vial, packaged with care, ensures a 24-month shelf life and superior convenience for prescribed hematologic malignancy therapies. Trust Bortenat for uncompromised therapeutic excellence.

Targeted Treatment for Hematologic Malignancies

Bortezomib 3.5mg Injection is specifically recommended for adults diagnosed with multiple myeloma or mantle cell lymphoma. Administered via intravenous or subcutaneous routes, it targets cancerous cells within the bloodstream and lymphatic system. Utilized exclusively in clinical settings, this injectable formulation is reconstituted with normal saline and should be administered under strict medical supervision to ensure patient safety and maximize efficacy. It is well-suited for oncology wards and specialized hematology clinics.

Global Export Excellence and Convenient Procurement

Bortezomib 3.5mg Injection is highly sought after in major international markets, including Asia, the Middle East, Africa, and Europe. Sample vials are available upon request for evaluation prior to large-scale orders. Most consignments are dispatched from prominent Indian FOB ports, with shipping estimates provided promptly. Our competitive sale price and proactive customer support ensure that procurement processes remain efficient for traders, suppliers, and healthcare organizations worldwide.

FAQ's of Bortezomib 3 5mg Injection:

Q: How should Bortezomib 3.5mg Injection be administered for optimal results?

A: Bortezomib injection is intended for intravenous or subcutaneous use only, preferably within a hospital or clinical setting, as directed by a qualified physician.

Q: What is the primary benefit of using Bortezomib 3.5mg Injection?

A: The main benefit is its outstanding effectiveness in treating multiple myeloma and mantle cell lymphoma, offering targeted anti-cancer action with a favorable safety profile when administered correctly.

Q: Where should the injection be stored before use?

A: Store the injection below 25C and protect it from light to maintain stability and potency until reconstitution is required.

Q: When is reconstitution of Bortezomib necessary and what diluent should be used?

A: Reconstitution is required prior to administration, using normal saline as the compatible diluent, and should be performed by healthcare professionals.

Q: What application surfaces are suitable for the injection?

A: For subcutaneous administration, the recommended sites are the thighs or abdomen; for intravenous use, it should be administered into an appropriate vein as guided by medical staff.

Q: What is the process for ordering and receiving Bortezomib for export?

A: Interested parties may request a sample vial. Upon agreement, shipments are dispatched from primary Indian FOB ports, with estimated timelines and sale prices communicated during the order process.

Tell us about your requirement